Smith & Nephew plc (LON:SN.)

Market Cap	10.50B
Revenue (ttm)	4.33B
Net Income (ttm)	358.03M
Shares Out	849.76M
EPS (ttm)	0.41
PE Ratio	30.36
Forward PE	15.15
Dividend	0.28 (2.33%)
Ex-Dividend Date	Oct 2, 2025

Volume	1,670,867
Average Volume	2,457,304
Open	1,227.50
Previous Close	1,217.00
Day's Range	1,220.50 - 1,235.50
52-Week Range	937.80 - 1,441.50
Beta	0.64
RSI	45.28
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,349
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN.

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD